Table 4.
In vitro MBCs comparing activities of 5 antimicrobial agents against 30 MSSA and 30 MRSA different isolates isolated from a clinical setting in largest Malaysian public hospital.
| Organism tested (no. of isolates) and antibiotic agent | MBC (μg/mL) | ||
|---|---|---|---|
| Range | 50% | 90% | |
| MSSA (30) | |||
| Vancomycin | 2–8 | 4 | 4 |
| Linezolid | 2–8 | 4 | 4 |
| Tigecycline | 0.25–1 | 0.25 | 0.5 |
| Daptomycin | 0.25–2 | 2 | 2 |
| Amox./clav. | 0.25–8 | 2 | 4 |
| MRSA (30) | |||
| Vancomycin | 2–8 | 4 | 4 |
| Linezolid | 0.5–4 | 4 | 4 |
| Tigecycline | 0.5–4 | 0.5 | 1 |
| Daptomycin | 0.125–4 | 1 | 2 |
| Amox./clav. | 2–32 | 4 | 24 |